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Background/Introduction
Post-cardiotomy cardiogenic shock (PCCS) occurs in
2-6% of patients undergoing surgical revascularization
or valvular surgery. Approximately 0.5-1.5% of patients
are refractory to maximal inotropic and intra-aortic bal-
loon counter pulsation (IABP) support. Refractory PCCS
leads to rapid multi-organ dysfunction syndrome and is
an almost universally fatal clinical state without
advanced mechanical circulatory support (AMCS) i.e.
extra-corporeal membrane oxygenation (ECMO) or ven-
tricular assist devices (VAD). However, the associated
major complications and cost related to such complex
devices has led to centralization of such valuable services
to only a few UK centers.
Aims/Objectives
We assessed the outcome of salvage AMCS for PCCS in a
non-transplant cardiothoracic surgery unit over an eleven-
year period.
Method
The data was gained through the Royal Infirmary of Edin-
burgh cardiac surgery database. Our inclusion criteria
included any patient from April 2004-April 2015 who had
received salvage Veno-Arterial ECMO or VAD for PCCS
(Cardiac Index < 2.2 L/min per square meter OR Systolic
BP < 90 mmHg) refractory to IABP and maximal inotropic
support following adult cardiac surgery.
Results
We identified 16 patients who met the inclusion criteria
in the aforementioned period. Age range was 34-83 years
(Median 71). There was a large male predominance of
12 (75%). Overall 15 patients (94%) had received ECMO
of which number, 12 (80%) had received central ECMO
and 3 (20%) had received peripheral ECMO. 1 patient
(6%) had VAD. Most common procedural related compli-
cation was haemorrhage. Massive stroke, Femoral artery
pseudo-aneurysm, septic shock, and renal failure also
occurred in this group. Overall survival was 31.2%. All sur-
vivors had NYHA class I-II on 24 months follow-up.
Discussion/Conclusion
Our survival rate is identical to the reported data from
previous studies. AMCS for refractory PCCS remains a
controversial approach his is perhaps due to the high cost
and serious complication rates. However the survivors
appear to continue living with an acceptable quality of life.
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